
### [NCIT:C26910](http://purl.obolibrary.org/obo/NCIT_C26910)
**Label:** Vaginal Disorder

**Subclasses:** [NCIT:C128073](http://purl.obolibrary.org/obo/NCIT_C128073) (Vaginal Neuroendocrine Carcinoma), [NCIT:C6379](http://purl.obolibrary.org/obo/NCIT_C6379) (Vaginal Yolk Sac Tumor), [NCIT:C7663](http://purl.obolibrary.org/obo/NCIT_C7663) (High Grade Vaginal Intraepithelial Neoplasia), [NCIT:C7981](http://purl.obolibrary.org/obo/NCIT_C7981) (Vaginal Adenocarcinoma), [NCIT:C7860](http://purl.obolibrary.org/obo/NCIT_C7860) (Recurrent Vaginal Carcinoma), [NCIT:C6333](http://purl.obolibrary.org/obo/NCIT_C6333) (Metastatic Malignant Neoplasm in the Vagina), [NCIT:C6374](http://purl.obolibrary.org/obo/NCIT_C6374) (Vaginal Squamous Papilloma), [NCIT:C40269](http://purl.obolibrary.org/obo/NCIT_C40269) (Endometrioid Stromal and Related Neoplasms of the Vagina), [NCIT:C6373](http://purl.obolibrary.org/obo/NCIT_C6373) (Vaginal Leiomyoma), [NCIT:C40265](http://purl.obolibrary.org/obo/NCIT_C40265) (Vaginal Soft Tissue Neoplasm), [NCIT:C40263](http://purl.obolibrary.org/obo/NCIT_C40263) (Vaginal Small Cell Carcinoma), [NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma), [NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma), [NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma), [NCIT:C4645](http://purl.obolibrary.org/obo/NCIT_C4645) (Grade 2 Vaginal Intraepithelial Neoplasia), [NCIT:C128080](http://purl.obolibrary.org/obo/NCIT_C128080) (Vaginal Rhabdomyosarcoma), [NCIT:C3437](http://purl.obolibrary.org/obo/NCIT_C3437) (Vaginal Neoplasm), [NCIT:C4521](http://purl.obolibrary.org/obo/NCIT_C4521) (Vaginal Intraepithelial Neoplasia), [NCIT:C4644](http://purl.obolibrary.org/obo/NCIT_C4644) (Low Grade Vaginal Intraepithelial Neoplasia), [NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma), [NCIT:C26910](http://purl.obolibrary.org/obo/NCIT_C26910) (Vaginal Disorder), [NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma), [NCIT:C40256](http://purl.obolibrary.org/obo/NCIT_C40256) (Vaginal Adenoma), [NCIT:C40257](http://purl.obolibrary.org/obo/NCIT_C40257) (Vaginal Tubular Adenoma), [NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma), [NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma), [NCIT:C40250](http://purl.obolibrary.org/obo/NCIT_C40250) (Vaginal Glandular Neoplasm), [NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma), [NCIT:C3917](http://purl.obolibrary.org/obo/NCIT_C3917) (Vaginal Carcinoma), [NCIT:C128112](http://purl.obolibrary.org/obo/NCIT_C128112) (Vaginal Germ Cell Tumor), [NCIT:C128113](http://purl.obolibrary.org/obo/NCIT_C128113) (Vaginal Teratoma), [NCIT:C128075](http://purl.obolibrary.org/obo/NCIT_C128075) (Vaginal Large Cell Neuroendocrine Carcinoma), [NCIT:C27394](http://purl.obolibrary.org/obo/NCIT_C27394) (Vaginal Melanoma), [NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma), [NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma), [NCIT:C40243](http://purl.obolibrary.org/obo/NCIT_C40243) (Vaginal Keratinizing Squamous Cell Carcinoma), [NCIT:C40242](http://purl.obolibrary.org/obo/NCIT_C40242) (Vaginal Squamous Neoplasm), [NCIT:C7737](http://purl.obolibrary.org/obo/NCIT_C7737) (Vaginal Sarcoma), [NCIT:C3610](http://purl.obolibrary.org/obo/NCIT_C3610) (Benign Vaginal Neoplasm), [NCIT:C7736](http://purl.obolibrary.org/obo/NCIT_C7736) (Vaginal Squamous Cell Carcinoma, Not Otherwise Specified), [NCIT:C128060](http://purl.obolibrary.org/obo/NCIT_C128060) (Vaginal Papillary Carcinoma), [NCIT:C6325](http://purl.obolibrary.org/obo/NCIT_C6325) (Vaginal Verrucous Carcinoma), [NCIT:C8944](http://purl.obolibrary.org/obo/NCIT_C8944) (Vaginal Metastatic Adenocarcinoma), [NCIT:C7735](http://purl.obolibrary.org/obo/NCIT_C7735) (Vaginal Clear Cell Adenocarcinoma), [NCIT:C6326](http://purl.obolibrary.org/obo/NCIT_C6326) (Vaginal Leiomyosarcoma), [NCIT:C7410](http://purl.obolibrary.org/obo/NCIT_C7410) (Malignant Vaginal Neoplasm), [NCIT:C40274](http://purl.obolibrary.org/obo/NCIT_C40274) (Vaginal Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C40275](http://purl.obolibrary.org/obo/NCIT_C40275) (Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C40272](http://purl.obolibrary.org/obo/NCIT_C40272) (Vaginal Undifferentiated Sarcoma), [NCIT:C40271](http://purl.obolibrary.org/obo/NCIT_C40271) (Low Grade Endometrioid Stromal Sarcoma of the Vagina), [NCIT:C4947](http://purl.obolibrary.org/obo/NCIT_C4947) (Vaginal Condyloma Acuminatum), 

**Class expressions from DL-Learner:**

- [NCIT:C26910](http://purl.obolibrary.org/obo/NCIT_C26910) (Vaginal Disorder) 99.04%
- [NCIT:C3437](http://purl.obolibrary.org/obo/NCIT_C3437) (Vaginal Neoplasm) 98.08%
- [NCIT:C7410](http://purl.obolibrary.org/obo/NCIT_C7410) (Malignant Vaginal Neoplasm) 76.92%
- [NCIT:C3917](http://purl.obolibrary.org/obo/NCIT_C3917) (Vaginal Carcinoma) 68.27%
- [NCIT:C27020](http://purl.obolibrary.org/obo/NCIT_C27020) (Female Reproductive System Disorder) 63.58%
- [NCIT:C3053](http://purl.obolibrary.org/obo/NCIT_C3053) (Female Reproductive System Neoplasm) 62.67%
- [NCIT:C4875](http://purl.obolibrary.org/obo/NCIT_C4875) (Reproductive System Disorder) 61.99%
- [NCIT:C3674](http://purl.obolibrary.org/obo/NCIT_C3674) (Reproductive System Neoplasm) 61.16%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 53.57%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 53.42%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 53.42%
- Thing 53.14%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 52.54%
- [NCIT:C4913](http://purl.obolibrary.org/obo/NCIT_C4913) (Malignant Female Reproductive System Neoplasm) 41.17%
- [NCIT:C36076](http://purl.obolibrary.org/obo/NCIT_C36076) (Malignant Reproductive System Neoplasm) 39.52%


